Propafenone (Adverse Reactions)

Propafenone is a class 1C antiarrhythmic drug, with sodium channel blocking properties, used in the treatment of atrial fibrillation or ventricular arrhythmias.

Propafenone is a class Ic antiarrhythmic drug used to treat certain types of cardiac arrhythmias, such as paroxysmal atrial fibrillation and ventricular tachycardias. It works by stabilizing the electrical activity of the heart by blocking sodium channels, helping to restore a normal heart rhythm.

It is administered orally or intravenously and requires medical monitoring, as it can have proarrhythmic effects in some patients.

MECHANISM OF ACTION

Propafenone is an antiarrhythmic that works by blocking sodium channels in heart cells, which leads to a decrease in the excitability of these cells. In addition to this, propafenone has additional beta-blocking activity that can also reduce heart rate.

CONTRAINDICATIONS

Treatment with propafenone is contraindicated in several situations due to its antiarrhythmic and cardiac conduction depressant effect, increasing the risk of sudden death in these cases. These include heart failure, conduction blocks, Brugada syndrome, electrolyte imbalances such as hypokalemia, chronic obstructive pulmonary disease, or severe bronchial asthma.

Propafenone is also contraindicated in patients with hypersensitivity to the drug or its excipients.

The drug should be administered with caution in elderly, diabetic, or hypotensive patients.

SIDE EFFECTS

Like all drugs, propafenone can cause a number of side effects. The most frequently reported include dizziness, irregular heartbeat, or palpitations. Anxiety, difficulty sleeping, headaches, altered taste, blurred vision, difficulty breathing, stomach pain, discomfort, diarrhea, liver disorders, or feeling tired, among others, may also occur, although less frequently.

INTERACTIONS

Propafenone can interact with other drugs. Among the drugs that can increase its levels, increasing the risk of toxicity, are CYP2D6 inhibitors, such as fluoxetine, paroxetine, amiodarone, or quinidine, CYP3A4 inhibitors, such as ketoconazole, ritonavir, or erythromycin, and CYP1A2 inhibitors, such as ciprofloxacin.

Drugs that can decrease propafenone levels and reduce its antiarrhythmic effect include CYP3A4 and CYP1A2 inducers, such as rifampicin, phenobarbital, or carbamazepine.

In addition, the combination of propafenone with other antiarrhythmics such as flecainide, quinidine, or amiodarone, SSRIs, or neuroleptics, may increase the risk of arrhythmia and ventricular block.

BRAND NAMES

  • Rythmol®
  • Rytmonorm®

Genes analyzed

CYP2D6

Bibliography

What do your genes say about you? Start your journey today.

Get a special 5% discount on your first kit.

Haven't you taken our DNA test yet?

Get your genetic test and discover what your DNA says about you.

pack
Starter DNA test
The best option to get started

Ancestry service, Traits and Wellness

Buy
pack
DNA test Advanced DNA test
Know your DNA in depth

Health, Ancestry service, Traits and Wellness

Buy
pack
Genetic analysisUltra
Whole Genome Sequencing 30x

Health, Ancestrality, Traits and Wellness

includes three months of tellmeGen+

Buy

Important information and limitations

Europe
Austria
Belgium
Czech Republic
Denmark
Finland
Germany
Hungary
Ireland
Italy
Netherlands
Norway
Poland
Portugal
Romania
Spain
Sweden
Switzerland
United Kingdom
Asia
Kazakhstan
Saudi Arabia
UAE
America
Brazil
Canada
Chile
Colombia
Mexico
Panama
Peru
United States
Oceania
Australia
The Best Prices of the Year! Only until November 27 Use our coupon BLACK15
Buy